CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2048
Detailed information
CancerLivER ID2048
Biomarker RBMY
Biomarker Name/Symbol (given in Publication)RBMY
BiomoleculeRNAs
SubjectHuman
Degree of Validityclassify HCC and LUAD tumors as TCN-active and TCN-silent group and validated on independent dataset
Experimental ConditionNormal vs cancer
Cancer typeHepatocellular carcinoma
Regulationupregulated in subsets of liver hepatocellular carcinoma (30%) and lung adenocarcinoma (10%)
Level of significance p < 0.05
SourceTissue
PMID27771326
Type of BiomarkerDiagnostic
Pathwayoncogenic pathway
Cohort137 matched pairs of male tumor and corresponding non-tumor samples including 27 cases of HCC (designated as LIHC in TCGA database), 24 cases of LUAD, 28 cases of HNSC, 10 cases of BLCA, 16 cases of KIRP, 16 cases COAD. Unpaired male tumor samples included 158 HCC cases and 184 LUAD cases. of THCA,
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseHuman HCC
Year of Publication2016
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top